Pulse Health was established in 2006 to bring noninvasive medical devices to consumers and health care professionals. Pulse Health’s free radical testing device, REVELAR™, uses breathalyzer technology to test damage caused by free radicals.  This is the first noninvasive device that provides access to health measurements previously unavailable to consumers.  With this new information, consumers can manage lifestyle choices with an eye toward making a positive impact on their health and wellness.

Consumers spend more than $30 billion on antioxidant supplements annually to fend off free radical damage.  Free radical damage is considered one of the major contributors to premature aging, atherosclerosis, cancer, Alzheimer’s disease and arthritis. REVELAR offers consumers a way to quickly and easily measure the effectiveness of their selected nutrition plans.

Pulse Health has a science advisory board of nine physicians and scientists from around the world, offering expertise and insight from a wide range of medical disciplines, including diagnostics, pulmonary disease, immunology, nutrition and biopharmaceuticals.